Goodwin Advises Sionna Therapeutics on the Closing of Its $219.2 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
February 13, 2025
February 13, 2025
BOSTON, Massachusetts, Feb. 13 -- Goodwin, a law firm, issued the following news release:
* * *
Goodwin Advises Sionna Therapeutics on the Closing of its $219.2 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
The Life Sciences team advised Sionna Therapeutics on the closing of its upsized initial public offering of 12,176,467 shares of its common stock at a public offering price of . . .
* * *
Goodwin Advises Sionna Therapeutics on the Closing of its $219.2 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
The Life Sciences team advised Sionna Therapeutics on the closing of its upsized initial public offering of 12,176,467 shares of its common stock at a public offering price of . . .